Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 01-2026 | 01-2025 | 01-2024 | 01-2023 | 01-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,087 | -2,628 | -2,147 | -7,172 | -9,709 |
| Depreciation Amortization | N/A | N/A | N/A | 14 | 15 |
| Accounts receivable | 6 | 20 | -17 | 237 | 145 |
| Other Working Capital | 871 | 546 | 238 | 2,627 | -1,051 |
| Other Operating Activity | -240 | 595 | 94 | 3,143 | 1,655 |
| Operating Cash Flow | $-449 | $-1,467 | $-1,831 | $-1,151 | $-8,946 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 295 | 888 | 222 | N/A | 96 |
| Debt Repayment | -4 | N/A | N/A | N/A | -200 |
| Common Stock Issued | 160 | 557 | 1,631 | 1,022 | 9,135 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -62 |
| Financing Cash Flow | $452 | $1,446 | $1,853 | $1,022 | $8,970 |
| Exchange Rate Effect | 0 | 0 | 0 | 2 | -10 |
| Beginning Cash Position | 6 | 27 | 6 | 133 | 124 |
| End Cash Position | 9 | 6 | 28 | 6 | 139 |
| Net Cash Flow | $3 | $-21 | $22 | $-126 | $15 |
| Free Cash Flow | |||||
| Operating Cash Flow | -449 | -1,467 | -1,831 | -1,151 | -8,946 |
| Free Cash Flow | -449 | -1,467 | -1,831 | -1,151 | -8,946 |